Observatory · observe first
Bristol Myers Squibb
BMY · United States · Pharmaceuticals · matched S&P 500 member. Follow its market-weight contribution.
Historical time machine
Historical observation
20182026
Universe weight
0.489%
12M weight contribution
-0.159 pp
3M weight contribution
+0.199 pp
12M price return
-19.8%
Share of matched S&P 500 members
Monthly observations through Feb 2019
Company price index
A separate dimension from market allocation
Historical observations
Most recent 24 observations at or before the selected month
| Month | Market cap | Universe weight | 12M weight change | 12M return | Above 6M weight average |
|---|---|---|---|---|---|
| Feb 2019 | $84.3bn | 0.489% | -0.159 pp | -19.8% | Yes |
| Jan 2019 | $80.6bn | 0.266% | -0.319 pp | -18.9% | No |
| Dec 2018 | $84.8bn | 0.303% | -0.281 pp | -15.3% | No |
| Nov 2018 | $87.3bn | 0.290% | -0.294 pp | -12.9% | No |
| Oct 2018 | $82.5bn | 0.280% | -0.305 pp | -17.6% | No |
| Sep 2018 | $101.3bn | 0.323% | -0.262 pp | +0.5% | No |
| Aug 2018 | $98.8bn | 0.319% | -0.265 pp | -2.0% | No |
| Jul 2018 | $95.9bn | 0.559% | -0.025 pp | -4.9% | No |
| Jun 2018 | $90.5bn | 0.549% | -0.036 pp | -11.0% | No |
| May 2018 | $86.0bn | 0.522% | -0.063 pp | -15.4% | No |
| Apr 2018 | $85.2bn | 0.524% | -0.061 pp | -16.2% | No |
| Mar 2018 | $103.3bn | 0.634% | +0.049 pp | +1.0% | Yes |
| Feb 2018 | $108.1bn | 0.648% | +0.063 pp | +5.8% | Yes |
| Jan 2018 | $102.5bn | 0.584% | +0.000 pp | +0.0% | No |
Its weight is estimated market cap divided by the total estimated market cap of matched S&P 500 members for the month. This is not an official float-adjusted S&P index weight.